Literature DB >> 3016788

Effects of trazodone treatment on alpha-2 adrenoceptor function in depressed patients.

L H Price, D S Charney, G R Heninger.   

Abstract

Tricyclic antidepressant drugs reduce the sensitivity of alpha 2 adrenoceptors during long-term treatment. In the present study, the alpha 2 adrenergic agonist clonidine was administered to 11 depressed patients before and during treatment with the triazolopyridine antidepressant trazodone (TRZ). Clonidine's ability to decrease blood pressure (BP) and plasma levels of the norepinephrine metabolite 3-methoxy-4-hydroxyphenylethyleneglycol (MHPG), and to increase sedation and plasma growth hormone (GH), were measured. TRZ had little effect on these indices of pre- and postsynaptic alpha 2 receptor function, suggesting that the antidepressant properties of TRZ are not related to changes in alpha 2 adrenoceptor sensitivity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3016788     DOI: 10.1007/bf00175186

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  67 in total

1.  Alpha-adrenergic drugs. Pharmacological tools for the study of the central vasomotor control.

Authors:  P Bousquet; J Schwartz
Journal:  Biochem Pharmacol       Date:  1983-05-01       Impact factor: 5.858

Review 2.  Regulation and function of noradrenaline receptor systems in brain. Psychopharmacological aspects.

Authors:  F Sulser
Journal:  Neuropharmacology       Date:  1984-02       Impact factor: 5.250

3.  Growth hormone response to clonidine unchanged by chronic clorgyline treatment.

Authors:  L J Siever; T W Uhde; T R Insel; B F Roy; D L Murphy
Journal:  Psychiatry Res       Date:  1982-10       Impact factor: 3.222

4.  The determination of a brain arteriovenous difference for 3-methoxy-4-hydroxyphenethyleneglycol (MHPG).

Authors:  J W Maas; S E Hattox; D H Landis; R H Roth
Journal:  Brain Res       Date:  1976-12-10       Impact factor: 3.252

5.  Effect of clonidine on growth hormone release in psychiatric patients and controls.

Authors:  N Matussek; M Ackenheil; H Hippius; F Müller; H T Schröder; H Schultes; B Wasilewski
Journal:  Psychiatry Res       Date:  1980-03       Impact factor: 3.222

6.  The acute effects of amitriptyline, iprindole and trazodone on blood pressure and heart rate in rats.

Authors:  J S Richardson; E K Chiu
Journal:  Pharmacol Biochem Behav       Date:  1982-12       Impact factor: 3.533

7.  Neurochemical lesion of the locus coeruleus of the rat does not suppress the sedative effect of clonidine.

Authors:  S Nassif; E Kempf; B Cardo; L Velley
Journal:  Eur J Pharmacol       Date:  1983-07-15       Impact factor: 4.432

8.  Postsynaptic serotonergic blockade following chronic antidepressive treatment with trazodone in an animal model of depression.

Authors:  J N Hingtgen; H C Hendrie; M H Aprison
Journal:  Pharmacol Biochem Behav       Date:  1984-03       Impact factor: 3.533

9.  alpha2-Adrenergic stimulation enhances growth hormone secretion in the dog: a presynaptic mechanism?

Authors:  S G Cella; G B Picotti; E E Müller
Journal:  Life Sci       Date:  1983-06-13       Impact factor: 5.037

10.  Alpha-2 adrenergic receptor sensitivity and the mechanism of action of antidepressant therapy. The effect of long-term amitriptyline treatment.

Authors:  D S Charney; G R Heninger; D E Sternberg
Journal:  Br J Psychiatry       Date:  1983-03       Impact factor: 9.319

View more
  3 in total

Review 1.  Trazodone. A review of its pharmacology, therapeutic use in depression and therapeutic potential in other disorders.

Authors:  M Haria; A Fitton; D McTavish
Journal:  Drugs Aging       Date:  1994-04       Impact factor: 3.923

2.  Beyond the limits of typical antidepressants.

Authors:  B Silvestrini
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

3.  Guanfacine modulates the influence of emotional cues on prefrontal cortex activation for cognitive control.

Authors:  Kurt P Schulz; Suzanne M Clerkin; Jin Fan; Jeffrey M Halperin; Jeffrey H Newcorn
Journal:  Psychopharmacology (Berl)       Date:  2012-10-20       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.